......"This will of course be good news for EXT as they will be one of the very very few companies that actually make it into production"......
Very true harlee.
Also after reading all the latest analyst reports last night,this from BMO really says it all for me......
----------------------------------------------------------------------------
5. Rössing South Offers Scalability
Production of 14.8Mlb p.a.
forecast.
Extract has released the initial results of preliminary feasibility work, which
outline a 15Mtpa operation to produce 14.8Mlb U3O8 a year. Throughput is in
line with Rössing’s capabilities, with the additional production a function of
higher grade, immediately demonstrating that the scale is in line with the
requirements of major producers.
BMO Research considers that the ultimate scalability of the project is likely to
be the most important metric that a senior producer will be looking for.
Based on 2008 figures, output of 14.8Mlb U3O8 per annum would make
Rössing South the second-largest producing mine within the BMO Research
universe of uranium producers
http://www.extractresources.com/InvestorInformation/ResearchReports/tabid/616/Default.aspx
-----------------------------------------------------------------------------
PS Apologies to the forum for my bourbon fuelled posts last night.
I do,however, think it's strange that Deutsche would have a HOLD reco when their 12 month target is less than today's share price.
I guess it's a "hold -just- in- case -our -analysis -is -wrong" recommendation.lol
Cheers!
- Forums
- ASX - By Stock
- EXT
- institutional interest growing
EXT
excite technology services ltd
Add to My Watchlist
11.1%
!
1.0¢

institutional interest growing, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $20.72M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.8¢ | $31.15K | 3.390M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1109800 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.009 |
6 | 1884688 | 0.008 |
7 | 5270700 | 0.007 |
4 | 2850000 | 0.006 |
2 | 1280000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 1109800 | 3 |
0.011 | 4227645 | 5 |
0.012 | 1982124 | 5 |
0.013 | 314500 | 2 |
0.014 | 1000000 | 1 |
Last trade - 15.23pm 27/06/2025 (20 minute delay) ? |
Featured News
EXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online